EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

SPECT in Alzheimers disease Perfusion patterns, demographics and correlations with the Alzheimers disease assessment scale-cognitive subscale



SPECT in Alzheimers disease Perfusion patterns, demographics and correlations with the Alzheimers disease assessment scale-cognitive subscale



Neurology 52(6 SUPPL 2): A367-A368, April 12




(PDF emailed within 1 workday: $29.90)

Accession: 035690131

Download citation: RISBibTeXText



Related references

Improved reliability of the standardized Alzheimers disease scale compared to the Alzheimers disease assessment scale. Journal of the American Geriatrics Society 44(9): S34, 1996

Temporal-lobe perfusion on SPECT predicts the rate of cognitive decline in Alzheimers disease. Journal of Clinical & Experimental Neuropsychology 15(1): 71, 1993

Improved reliability of the Standardized Alzheimers Disease Assessment Scale compared with the Alzheimers Disease Assessment Scale. Journal of the American Geriatrics Society 44(6): 712-716, 1996

Quantitative global assessment of cerebral perfusion changes via 3D perfusion isosurfaces in patients with Alzheimers disease using Iodine-123-IMP SPECT and autoradiography protocol. Journal of Nuclear Medicine 44(5 Supplement): 17P, 2003

SPECT assessment of parietal and temporal lobe perfusion in possible and probable Alzheimers disease. Clinical Nuclear Medicine 19(3): 267, 1994

Similarity of brain perfusion patterns demonstrated with hmpao spect in sleep apnea and alzheimers disease. Journal of Nuclear Medicine 31(5 SUPPL): 877, 1990

A Chinese version of the cognitive component of the Alzheimers Disease Assessment Scale. Neurology 56(8 Supplement 3): A174, April 24, 2001

Perfusion SPECT and functional MRI in Alzheimers disease. Journal of Nuclear Medicine 36(5 SUPPL ): 107P-108P, 1995

Longitudinal assessment of probable alzheimers disease 2 year follow up data from the consortium to establish a registry for alzheimers disease cerad. Neurology 40(4 SUPPL 1): 450, 1990

Spect evaluation of cerebral perfusion abnormalities in alzheimers disease. Journal of Nuclear Medicine 33(5 SUPPL): 973, 1992

Atrophy-corrected SPECT cerebral perfusion in Alzheimers disease. Neurology 44(4 SUPPL 2): A179, 1994

MRI volumetric sampling of SPECT perfusion in prodromal Alzheimers disease. Neurology 54(7 Supp 3): A78, April 11, 2000

The ABC of Alzheimers Disease: Cognitive Changes and Their Management in Alzheimers Disease and Related Dementias. International Psychogeriatrics 14(S1): 51-75, 2002

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimers disease: ADAS-cog subscale results from the Alphase study. Journal of Nutrition, Health & Aging 13(9): 808-812, 2009

Comparison of parietal SPECT perfusion and proton MRS measures of NAA in Alzheimers disease. Neurology 44(4 SUPPL 2): A179-A180, 1994